Dis-application of Rules 18A.09 to 18A.11 of the Listing Rules

Voluntary Announcement Biologics License Application for Boyounuo Accepted in Brazil

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023

BLA for Boan's Boyounuo® (Bevacizumab) Accepted in Brazil

Boan Biotech today announced that Brazil's Agência Nacional de Vigilância Sanitária (ANVISA) has accepted the company's Biologic License Application (BLA) for Boyounuo® (Bev...

Connected Transaction Rent Sharing Agreement

Boan Biotech Announces 2022 Financial Results

Boan Biotech (6955.HK) announced its 2022 financial results and recent business developments on March 27, 2023.2022 business highlightsRecord high in revenueIn 2022, Boan Biotech's revenue was app...

Terms of Reference of the Environmental, Social and Governance Committee of the Board

List of Directors and their Roles and Functions

Terms of reference of the environmental social and governance committee of the board

BLA Accepted in China for Boan Biotech’s Denosumab Injection (BA1102) for the Oncology Indications

Yantai, China, March 21, 2023 —Boan Biotech today announced that the Biologics License Application (BLA) for BA1102 (Denosumab Injection), a biosimilar for the oncology indications, has been accepted...